跳至主要内容
临床试验/DRKS00029761
DRKS00029761招募中不适用

Digital preventive measures for arterial hypertension

Medizinische Hochschule Brandenburg Campus GmbH0 个研究点目标入组 2,510 人开始时间: 2022年7月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,510

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Module 1 Interviews: Presence of arterial hypertension,
  • Module 1 questionnaires: presence of arterial hypertension and covered by the AOK Nordost.
  • Module 2a: participation in a behavioral prevention course offered by AOK Nordost,
  • Module 2b: Use of a hypertension app within the last two years,
  • Module 3a: Current outpatient activity as a family doctor/family physician,
  • Module 3b: Current activity as a specialist in cardiology.

排除标准

  • Patients should be able to speak German and understandable oral communication should not be an obstacle. There should be no severe impairment of mental and cognitive abilities.

研究者

相似试验

进行中(未招募)
不适用
Prevención de la progresión de la hipertensión portal en la cirrosis compensada mediante el uso de vasodilatadores hepáticos selectivos. Estudio multicéntrico, aleatorizado y doble-ciego - SIMPROEl objetivo de estudio es valorar el efecto de las estatinas, en su efecto vasodilatador selectivo hepático, en la prevención de la progresión de la hipertensión portal ( con un gradiente de presión entre 6 y 10 mmHg) en pacientes con cirrosis hepática compensada.MedDRA version: 12.1Level: HLTClassification code 10036201Term: Portal hypertensions
EUCTR2010-021593-11-ESINSTITUT DE RESERCA.HSCSP
已完成
不适用
Effectiveness of community intervention programHypertension
ISRCTN88146057Griffith University (Australia)1,600
已完成
不适用
Aggressive antihypertensive treatment for protecting cardiovascular complications in pre-diabetic hypertensive patients1.Hypertensive patients with diabetes mellitus (DM), pre-diabetes: DM was defined as at least one of the following criteria: fasting blood glucose &gt=126mg/dl, 2-hour glucose in 75gOGTT &gt=200mg/dl, HbA1c &gt=6.1%, or treated diabetes.Pre-diabetes was diagnosed as HbA1c &gt=5.7%
JPRN-UMIN000005541Jichi Medical University School of Medicine60
已完成
不适用
Aggressive antihypertensive treatment for protecting cardiovascular complications in diabetic and pre-diabetic hypertensive patients1.Hypertensive patients with diabetes mellitus (DM), pre-diabetes: DM was defined as at least one of the following criteria: fasting blood glucose &gt=126mg/dl, 2-hour glucose in 75gOGTT &gt=200mg/dl, HbA1c &gt=6.1%, or treated diabetes.Pre-diabetes was diagnosed as HbA1c &gt=5.7%
JPRN-UMIN000005743Jichi Medical University,School of Medicine60
已完成
不适用
Methods of implementing guidelines for hypertension in primary care: acceptability, effectiveness and cost-effectivenessCardiovascular diseases: HypertensionCirculatory SystemHypertension
ISRCTN16617840HS R&D Regional Programme Register - Department of Health (UK)